C12N 2770/32323
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2770/32323 (Virus like particles [vlp]) appears on 9 US grants and 15 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 15
- Assignees
- 9
- Inventors
- 37
- Latest grant
- 18 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 4 |
| 2016 | 1 | 3 |
| 2017 | 1 | 1 |
| 2018 | 2 | 2 |
| 2019 | 1 | 2 |
| 2020 | 3 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Engineered Hansenula fungi efficiently expressing CA10 virus-like particles and uses thereof18 Mar 2025US 12,251,435 B2Beijing Minhai Biotechnology Co., Ltd.
- Picornavirus-like particle production in plants17 Mar 2020US 10,590,173 B2Medicago Inc.
- Antigens and vaccines directed against human enteroviruses11 Feb 2020US 10,555,997 B2SENTINEXT THERAPEUTICS Sdn Bhd
- Antigens and vaccines directed against human enteroviruses4 Feb 2020US 10,548,964 B2SENTINEXT THERAPEUTICS Sdn Bhd
- Picornavirus-like particle production in plants12 Feb 2019US 10,202,423 B2Medicago Inc. of Quebec, Canada
- Coxsackievirus B Compositions and Methods Of Use Thereof20 Nov 2025US 2025/0352634 A1Vactech Oy
- Hansenula engineering fungi efficiently expressing ca10 virus-like particles and use thereof21 Apr 2022US 2022/0118075 A1Beijing Minhai Biotechnology Co., Ltd.
- Chimeric enterovirus virus-like particles25 Jul 2019US 2019/0224304 A1SENTINEXT THERAPEUTICS Sdn Bhd
- Picornavirus-like particle production in plants18 Apr 2019US 2019/0112341 A1Medicago Inc.
- Antigens and vaccines directed against human enteroviruses27 Sep 2018US 2018/0271971 A1SENTINEXT THERAPEUTICS Sdn Bhd
Most cited
By later US patents